Outbreak spotlights safety of custom-mixed drugs

October 4, 2012 by Marilynn Marchione

Custom-mixed medicines like the steroid shots suspected in a meningitis outbreak have long been a source of concern, and their use is far wider than many people realize.

These medicines are made in private and hospital pharmacies and used to treat everything from cancer to menopause symptoms to .

Often these products are name-brand medicines split into smaller doses, or mixed from ingredients sold in bulk. That can easily lead to contamination if aren't maintained. The germ suspected in the current outbreak can spread in the air.

A shortage of many drugs has forced doctors to stretch supplies and seek custom-made alternatives if the first-choice treatment was not available.

The meningitis outbreak has killed four and sickened at least two dozen in five states.

Explore further: Rare US fungal meningitis outbreak grows; 5 dead (Update)

shares

Related Stories

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 3, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

10 people die of suspected Ebola in Congo

August 22, 2012
(AP) — The World Health Organization says an outbreak of suspected Ebola in eastern Congo has infected at least 15 people, 10 of whom died.

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 4, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

Sierra Leone says cholera killed 66 since January

July 21, 2012
(AP) — Sierra Leone's health ministry says a cholera outbreak has sickened more than 3,800 and killed 66 people since January.

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.